Chopra, Slaughter: FTC approval of Pfizer/Mylan may invite collusion

Both Democratic members of the Federal Trade Commission have warned that the conditional approval of Pfizer’s sale of its Upjohn division to Mylan may make it easier for companies in the pharmaceutical industry to coordinate prices.


Get unlimited access to all Global Competition Review content